Presentations

Lexeo Q3 2024 Program Updates 560.2 KB

Lexeo Corporate Presentation - November 2024 2.5 MB

International Congress for Ataxia Research – Lexeo Presentation November 2024 915.5 KB

Interim Phase 1/2 Clinical Data of LX1001 for the Treatment of APOE4-Associated Alzheimer’s Disease – October 2024 1.3 MB

Interim Phase 1/2 Clinical Data of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy – July 2024 1.5 MB